Trademark: 97859267
Word
TIGVANZA
Status
Pending
Status Code
730
Status Date
Wednesday, July 31, 2024
Serial Number
97859267
Mark Type
4
Filing Date
Monday, March 27, 2023
Published for Opposition
Tuesday, January 23, 2024

Trademark Owner History
BeiGene Switzerland GmbH - Owner At Publication

Classifications
5 Medicines, pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer and rheumatoid arthritis; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases

Trademark Events
Apr 18, 2023
New Application Office Supplied Data Entered
Dec 20, 2023
Assigned To Examiner
Mar 30, 2023
New Application Entered
Dec 21, 2023
Approved For Pub - Principal Register
Jan 3, 2024
Notification Of Notice Of Publication E-Mailed
Jan 23, 2024
Published For Opposition
Jul 31, 2024
Sou Teas Extension Received
Jul 31, 2024
Notice Of Approval Of Extension Request E-Mailed
Jul 31, 2024
Sou Extension 1 Granted
Jul 31, 2024
Sou Extension 1 Filed
Jan 23, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 19, 2024
Noa E-Mailed - Sou Required From Applicant

Trademark Alertz updated from USPTO on 2030-01-24